{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T20:46:21Z","timestamp":1764276381893},"reference-count":24,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T00:00:00Z","timestamp":1138752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,3]],"date-time":"2019-12-03T00:00:00Z","timestamp":1575331200000},"content-version":"vor","delay-in-days":5053,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2006,2]]},"DOI":"10.1093\/annonc\/mdj077","type":"journal-article","created":{"date-parts":[[2005,11,18]],"date-time":"2005-11-18T01:25:26Z","timestamp":1132277126000},"page":"262-269","source":"Crossref","is-referenced-by-count":62,"title":["Randomized phase III trials of adjuvant FAMTX or FEMTX compared with surgery alone in resected gastric cancer. A combined analysis of the EORTC GI Group and the ICCG"],"prefix":"10.1016","volume":"17","author":[{"given":"D.","family":"Nitti","sequence":"first","affiliation":[]},{"given":"J.","family":"Wils","sequence":"additional","affiliation":[]},{"given":"J. Guimaraes","family":"Dos Santos","sequence":"additional","affiliation":[]},{"given":"G.","family":"Fountzilas","sequence":"additional","affiliation":[]},{"given":"P.F.","family":"Conte","sequence":"additional","affiliation":[]},{"given":"C.","family":"Sava","sequence":"additional","affiliation":[]},{"given":"A.","family":"Tres","sequence":"additional","affiliation":[]},{"given":"R.C.","family":"Coombes","sequence":"additional","affiliation":[]},{"given":"D.","family":"Crivellari","sequence":"additional","affiliation":[]},{"given":"A.","family":"Marchet","sequence":"additional","affiliation":[]},{"given":"E.","family":"Sanchez","sequence":"additional","affiliation":[]},{"given":"J.M.","family":"Bliss","sequence":"additional","affiliation":[]},{"given":"J.","family":"Homewood","sequence":"additional","affiliation":[]},{"given":"M.L.","family":"Couvreur","sequence":"additional","affiliation":[]},{"given":"E.","family":"Hall","sequence":"additional","affiliation":[]},{"given":"B.","family":"Baron","sequence":"additional","affiliation":[]},{"given":"E.","family":"Woods","sequence":"additional","affiliation":[]},{"given":"M.","family":"Emson","sequence":"additional","affiliation":[]},{"given":"E.","family":"Van Cutsem","sequence":"additional","affiliation":[]},{"given":"M.","family":"Lise","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdj077_bb0010","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/00000658-199810000-00002","article-title":"Relevant prognostic factors in gastric cancer. Ten-year results of the German gastric cancer study","volume":"228","author":"Siewert","year":"1998","journal-title":"Ann Surg"},{"key":"10.1093\/annonc\/mdj077_bb0015","first-page":"616","article-title":"Gastric carcinoma: does lymph node dissection alter the survival?","volume":"183","author":"Wanebo","year":"1996","journal-title":"J Am Coll Surg"},{"key":"10.1093\/annonc\/mdj077_bb0020","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s101200050006","article-title":"Clinicopathologic characteristics and prognostic factors in 10783 patients with gastric cancer","volume":"1","author":"Kim","year":"1998","journal-title":"Gastric Cancer"},{"key":"10.1093\/annonc\/mdj077_bb0025","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1200\/JCO.1991.9.5.827","article-title":"Sequential high-dose methotrexate and fluorouracil combined with doxorubicin\u2014a step ahead in the treatment of advanced gastric cancer: a trial of the European Organization for Research and Treatment of Cancer, Gastrointestinal Tract Cooperative Group","volume":"9","author":"Wils","year":"1991","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdj077_bb0030","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1200\/JCO.1997.15.1.261","article-title":"Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophago-gastric cancer","volume":"15","author":"Webb","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdj077_bb0035","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1056\/NEJM199903253401202","article-title":"Extended lymph-node dissection for gastric cancer","volume":"340","author":"Bonenkamp","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdj077_bb0040","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1038\/sj.bjc.6690243","article-title":"Patient survival after D1 and D2 resections for gastric cancer. Long term results of the MRC randomized surgical trial","volume":"79","author":"Cuschieri","year":"1999","journal-title":"Br J Cancer"},{"key":"10.1093\/annonc\/mdj077_bb0045","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/BF02307082","article-title":"Prognostic factors in resectable gastric cancer: results of EORTC Study No","volume":"2","author":"Lise","year":"1995","journal-title":"40813 on FAM adjuvant chemotherapy. Ann Surg Oncol"},{"key":"10.1093\/annonc\/mdj077_bb0050","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1056\/NEJM199903253401210","article-title":"Lymph node dissection for gastric cancer","volume":"340","author":"Brennan","year":"1999","journal-title":"New Engl J Med"},{"key":"10.1093\/annonc\/mdj077_bb0055","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1111\/j.1365-2168.1997.02842.x","article-title":"Risk factors for surgical treatment in the Dutch Gastric Cancer Trial","volume":"84","author":"Sasako","year":"1997","journal-title":"Br J Surg"},{"key":"10.1093\/annonc\/mdj077_bb0060","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/BF02573066","article-title":"Fitzsimmons T for the Southwest Oncology Group and the Gastric Intergroup. Surgical treatment variation in a prospective, randomized trial of chemoradiotherapy in gastric cancer: the effect of undertreatment","volume":"9","author":"Hundahl","year":"2002","journal-title":"Ann Surg Oncol"},{"key":"10.1093\/annonc\/mdj077_bb0065","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1200\/JCO.2004.08.026","article-title":"Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch Gastric Cancer Group Trial","volume":"22","author":"Hartgrink","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdj077_bb0070","first-page":"397","article-title":"The treatment of advanced gastric cancer","volume":"23","author":"Wils","year":"1996","journal-title":"Semin Oncol"},{"key":"10.1093\/annonc\/mdj077_bb0075","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1093\/annonc\/mdi270","article-title":"Adjuvant chemotherapy with 5-fluorouracil and cisplatin compared with surgery alone for gastric cancer: 7-year results of the FFCD randomized phase III trial (8801)","volume":"16","author":"Bouche","year":"2005","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdj077_bb0080","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1093\/annonc\/mdf040","article-title":"Adjuvant chemotherapy in gastric cancer: 5-year results of a randomized study by the Italian Trials in Medical Oncology (ITMO) Group","volume":"13","author":"Bajetta","year":"2002","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdj077_bb0085","first-page":"296a","article-title":"Postoperative chemotherapy (CT) in resected gastric cancer (GC) follow-up (FUP) vs PELF Results of an Italian intergroup (GOIRCGISCAD) study","volume":"22","author":"Di Costanzo","year":"2003","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1093\/annonc\/mdj077_bb0090","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1056\/NEJMoa010187","article-title":"Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction","volume":"345","author":"Macdonald","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdj077_bb0095","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1200\/JCO.1993.11.8.1441","article-title":"Adjuvant therapy after curative resection for gastric cancer: meta-analysis of randomized trials","volume":"11","author":"Hermans","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdj077_bb0100","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0959-8049(99)00076-3","article-title":"Adjuvant chemotherapy after resection for gastric cancer in non-Asian patients: revisiting a meta-analysis of randomised trials","volume":"35","author":"Earle","year":"1999","journal-title":"Eur J Cancer"},{"key":"10.1093\/annonc\/mdj077_bb0105","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1023\/A:1008377101672","article-title":"Efficacy of adjuvant chemotherapy after curative resection for gastric cancer: a meta-analysis of published trials: Study of the GISCAD","volume":"11","author":"Mari","year":"2000","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdj077_bb0110","first-page":"21","article-title":"Adjuvant chemotherapy in gastric cancer: a meta-analysis of randomized trials and a comparison with previous meta-analysis","volume":"88","author":"Panzini","year":"2002","journal-title":"Tumori"},{"key":"10.1093\/annonc\/mdj077_bb0115","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.3748\/wjg.v8.i6.1023","article-title":"Intravenous chemotherapy for resected gastric cancer: meta-analysis of randomized controlled trials","volume":"8","author":"Hu","year":"2002","journal-title":"World J Gastroenterol"},{"key":"10.1093\/annonc\/mdj077_bb0120","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/00000658-199103000-00006","article-title":"Mitomycin C as an adjuvant treatment to resected gastric cancer","volume":"213","author":"Estape","year":"1991","journal-title":"Ann Surg"},{"key":"10.1093\/annonc\/mdj077_bb0125","first-page":"308s","article-title":"Perioperative chemotherapy in operable gastric and lower esophageal cancer Final results of a randomized controlled trial (the MAGIC trial ISRCTN 93793971)","volume":"23","author":"Cunningham","year":"2005","journal-title":"Proc Am Soc Clin Oncol"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419403888?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419403888?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/17\/2\/262\/392956\/mdj077.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,23]],"date-time":"2021-06-23T07:38:00Z","timestamp":1624433880000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419403888"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,2]]}},"alternative-id":["S0923753419403888"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdj077","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2006,2]]}}}